Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Charles Perry

Plastic Surgery Sacramento, CA Medical Doctor

NPI 1992883664 CMS profile 226470

785 University Ave, Chrysalis Cosmetics, Sacramento, CA 95825

Open in the dashboard

General payments

$10,115

130 records reported · program years 2019–2025

Research payments

$1,500

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Charles Perry of Sacramento, CA is reported in the CMS Open Payments database as having received $10,115 across 130 general payments and $1,500 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 85th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $730 12
2024 General $660 13
2023 General $548 12
2022 General $249 15
2022 Research $500 1
2021 General $4,851 25
2021 Research $500 1
2020 General $1,926 21
2020 Research $500 1
2019 General $1,151 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Charles Perry
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Charles Perry were reported at $730. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Charles Perry Plastic Surgery median Middle half National median
2019 $1,151 $371 $122–$1,483 $163
2020 $1,926 $158 $52–$438 $114
2021 $4,851 $249 $87–$752 $132
2022 $249 $274 $102–$793 $149
2023 $548 $299 $113–$891 $160
2024 $660 $361 $124–$1,062 $164
2025 $730 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Baudax Bio Inc. $4,487 11 payments
  2. Musculoskeletal Transplant Foundation Inc. $1,910 5 payments
  3. Allergan Inc. $1,161 56 payments
  4. Mentor Worldwide LLC $669 14 payments
  5. AbbVie, Inc. $558 20 payments
  6. Innovation Technologies Inc $225 2 payments
  7. Motiva USA, LLC $225 1 payment
  8. Sientra, Inc. $208 8 payments
  9. Integra LifeSciences Corporation $206 2 payments
  10. Vertex Pharmaceuticals Incorporated $97 1 payment
  11. Other $369 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,860 127 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,400 1 payment
  3. Honoraria $1,105 1 payment
  4. Consulting Fee $750 1 payment
Products named General payments · program years 2019–2025
  1. ANJESO $4,487 11 payments
  2. BOTOX $661 30 payments
  3. MENTOR MemoryGel Resterilizable Gel Sizer $396 9 payments
  4. BOTOX COSMETIC $288 17 payments
  5. MemoryGel Breast Implants $268 4 payments
  6. NATRELLE $265 11 payments
  7. Irrisept $225 2 payments
  8. Motiva Implant Matrix $225 1 payment
  9. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $208 8 payments
  10. ARTOURA Breast Tissue Expander $154 2 payments
  11. Other $1,615 26 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Sientra, Inc. $1,500 3 payments

Records

133 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record